Journal of Bone and Mineral Research
Publication Venue For
Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment
New and Unexpected Roles for Primary Cilia in Coordinating Response to Mechanical Load in Articular and Growth Plate Cartilages
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial
Racial and Ethnic Disparities in Bone Health and Outcomes in the United States
Genome-wide Association Studies Reveal Novel Locus With Sex-/Therapy-Specific Fracture Risk Effects in Childhood Cancer Survivors
Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former Smokers
Secular Trends in the Incidence of Hip Fracture Among Nursing Home Residents
Both NPY-Expressing and CART-Expressing Neurons Increase Energy Expenditure and Trabecular Bone Mass in Response to AP1 Antagonism, But Have Opposite Effects on Bone Resorption
Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart
American Society for Bone and Mineral Research-Orthopaedic Research Society Joint Task Force Report on Cell-Based Therapies
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition
Specific RANK Cytoplasmic Motifs Drive Osteoclastogenesis
The Design and Validation of a New Algorithm to Identify Incident Fractures in Administrative Claims Data
ΔFosB Requires Galanin, but not Leptin, to Increase Bone Mass via the Hypothalamus, but both are needed to increase Energy expenditure
Cost-Effectiveness of Osteoporosis Screening Using Biomechanical Computed Tomography for Patients With a Previous Abdominal CT
Association of Dietary Niacin Intake With Incident Hip Fracture, BMD, and Body Composition: The Cardiovascular Health Study
Glucocorticoid Exposure and Fracture Risk in a Cohort of US Patients With Selected Conditions
Specificity Protein 7 Is Required for Proliferation and Differentiation of Ameloblasts and Odontoblasts
Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial
Prevalence of Osteoporosis and Low Bone Mass Among Puerto Rican Older Adults
The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial
Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward
Impact of Competing Risk of Mortality on Association of Weight Loss With Risk of Central Body Fractures in Older Men: A Prospective Cohort Study
The Association Between Protein Intake by Source and Osteoporotic Fracture in Older Men: A Prospective Cohort Study
Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2
Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS)
What Proportion of Incident Radiographic Vertebral Fractures in Older Men Is Clinically Diagnosed and Vice Versa: A Prospective Study
Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women
Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study
Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density
Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus
Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis
Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: The global longitudinal study of osteoporosis in women (GLOW)
Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research
Risk factors for treatment failure with antiosteoporosis medication: The global longitudinal study of osteoporosis in women (GLOW)
A close examination of healthcare expenditures related to fractures
A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women
Recent trends in hip fracture rates by race/ethnicity among older US adults
Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus
Serum response factor regulates bone formation via IGF-1 and Runx2 signals
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes
Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial.
Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women
Predicting fractures in an international cohort using risk factor algorithms without BMD
Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The women's health initiative (WHI)
Stronger bone correlates with African admixture in African-American women
Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1
Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294))
Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators
APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner
The relationship between bisphosphonate adherence and fracture: Is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines
Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis
Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men
Ferritin ferroxidase activity: A potent inhibitor of osteogenesis
Lower bone mass in prepubertal overweight children with prediabetes
Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men
Health care expenditures associated with skeletal fractures among medicare beneficiaries, 1999-2005
High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men
Myeloma bone disease
Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis
Bridging the osteoporosis quality chasm
Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the women's health initiative hormone intervention trials
A Runx2 Threshold for the Cleidocranial Dysplasia Phenotype.
Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users
Induction of Runx2 and Osterix by Bisphosphonate Promote Osteogenic Differentiation
Calcium channel TRPV6 is involved in murine maternal-fetal calcium transport
HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE
Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005
Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling
Doubly truncated FosB isoform (Δ2ΔFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity
Genetic and pharmacologic activation of the hypoxia inducible factor pathway promotes angiogenesis and accelerates bone regeneration
Growth inhibition of osteoblast progenitors by Runx2 depends on its C-terminal regulatory domain and is accompanied by changes in G-Protein coupled signaling pathways
Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene
Predictors of non-spine fracture in elderly men: The MrOS study
Krüppel-like zinc finger protein Glis3 promotes osteoblast differentiation by regulating FGF18 expression
Defects in intranuclear localization of Runx2 alter osteoblast differentiation ex vivo.
Mitotic retention of the bone phenotype by the cell fate determining transcription factor Runx2.
Post-mitotic expression of transcription factor RUNX2 defines a novel regulatory transition during the G1 phase of proliferating Pre-Osteoblasts.
Specific residues of Runx2/Cbfa1 direct Osteoblast differentiation and integration of BMP2 osteogenic signal.
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: Results from the women's health initiative randomized trial
RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts
RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity
A critical point mutation in the Runx2 subnuclear targeting domain abrogates osteogenic function by blocking integration of the BMP2 signal
Inactivation of Nek1 protein kinase signaling in Kat2J mice leads to skeletal defects.
Microarray analysis of differential gene expression in OSCC cell lines.
Msx2 antagonizes Runx2 regulation of osteolytic activity in breast cancer cells.
Reconstitution of Runx2/Cbfa1null cells identifies Runx2 domains required for osteoblast differentiation
Runx2 association with microtubules: A potential role in nucleo-cytoplasmic shuttling.
The Runx2 transcription factor supports expression of genes coupled to the invasive and osteolytic properties of breast cancer cells.
Comparative effect of soy protein, soy isoflavones, and 17β-estradiol on bone metabolism in adult ovariectomized rats
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
Contributions of nuclear structure-function relationships to the onset and progression of tumorigenesis
Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossification
RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
Runx2 regulates tumor cell invasive properties and contributes to the osteolytic bone disease associated with metastatic cancer cells
Runx2/Msx2 interactions regulating breast cancer-induced osteolysis in bone
Convergence of BMP2/TGF beta MAPK and Runx2 signaling in subnuclear foci during osteogenic lineage induction
Dlx3 is a transcriptional regulator of osteoblast differentiation and increases expression and promoter activity of Runx2.
Establishment of a mechanistic link between the osteogenic function of Runx2 and its sulnuclear organization by intranuclear informatics.
Expression pattern of core binding factor-beta in skeletal tissues
Multiple nuclei in osteoclasts functionally compartmentalize gene regulatory machinery
Wnt signaling regulates Runx2 expression in vivo and activates the bone-related Runx2 P1 promoter
Ectopic Runx2 regulates breast cancer metastasis-associated osteolytic disease
Chromatin remodeling of the proximal rat osteocalcin promoter is dependent on vitamin D receptor binding at the distal promoter element
Ectopic runx2 regulates breast cancer metastasis associated osteolytic disease
Subnuclear targeting supports functional interrelationships between Runx2 and the BMP-2 regulated Smad 1 protein
Radioguided Parathyroidectomy for Recurrent Hyperparathyroidism Caused by Forearm Graft Hyperplasia
Cbfb, a well-known, regulator of hematopoiesis, cooperates with Cbfa1 and plays a critical role in bone development.
Runx factors are expressed in the osteoclast and regulated during osteoclast differentiation.
Runx1(Cbfa2/AML1) is expressed in tissues supporting osteogenesis and temporally regulated during chondrocyte and osteoblast differentiation.
Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: The Framingham study
Radioguided parathyroidectomy via VATS combined with intraoperative parathyroid hormone testing: The surgical approach of choice for patients with mediastinal parathyroid adenomas?
Developmental utilization of distinct promoters regulating the type I and type II isoforms of the bone Runx2/Cbfa1 transcription factor.
Forced expression of Runx2/Cbfa1 driven by the -3.6 kb Collagen Type I promoter results in a normal phenotype in transgenic mice.
Runx2-C/EBP molecular interactions and functional synergism support maximal expression of osteocalcin in osteoblasts.
Trafficking of Runx1/Cbfa2 and Runx2/Cbfa1 in living cells defines a dynamic subnuclear domain.
Acidic fibroblast growth factor signaling inhibits peroxynitrite-induced death of osteoblasts and osteoblast precursors
The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis
Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats
C/EBP is a potent activator of osteocalcin gene transcription.
In vivo replacement of the Runx2/Cbfa1 gene with a mutant gene lacking a subnuclear targeting signal and transcriptional regulatory functions results in severe skeletal abnormalities.
RUNX (CBFalpha/AML/PEBP2alpha) dependent repression of tissue-specific gene transcription involves in situ association with Groucho/TLE/R-esp proteins.
Rapid epiphyseal trabecular bone resorption in high-dose corticosteroid treatment correlates with osteocytic apoptosis and passive tetracycline uptake, while cytokine expression patterns in vitro implicate an alternative osteoclast induction mechanism.
C/EBP family members are expressed in osteoblast and are involved in regulation of osteocalcin gene transcription.
Cbfa family members act as a negative regulator of the bone sialoprotein gene.
Contributions of nuclear architecture to bone-specific and steroid hormone regulation of osteocalcin gene transcription.
Resorption and microfractures precede vascular changes in subarticular bone with high-dose glucocorticoid treatment.
Structure-function determinants for subnuclear targeting and transactivation in the Cbfa1/AML3 transcription factor.
The C-terminus of CBFA1 supports subnuclear trafficking of green fluorescent protein tagged-CBFA1.
Expression of nitric oxide synthase isoforms in bone and bone cell cultures
The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density
A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone γ‐carboxyglutamic acid (Gla)‐containing protein in osteoblasts
Mechanism of fibroblast attachment to bone extracellular matrix: Role of a 44 kilodalton bone phosphoprotein
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)